Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
47
LCTX Quote, Financials, Valuation and Earnings
Last price:
$1.00
Seasonality move
:
4.41%
Day range:
$1.01 - $1.06
52-week range:
$0.37 - $1.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.52x
P/B ratio:
2.95x
Volume:
1.4M
Avg. volume:
3.5M
1-year change:
-4.67%
Market cap:
$232.9M
Revenue:
$9.5M
EPS (TTM):
-$0.08
Earnings Data
Next earnings date for LCTX
Aug 08
2025
Most recent earnings per share
-$0.02
Beat by $0.01
(May 13/2025)
Consensus Estimate
-$0.03
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LCTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $1.9M | -- | -- | -$0.03 | -- |
| 08/08/2025 | Q2 | $1.5M | -- | -- | -$0.03 | -- |
| 05/13/2025 | Q1 | $1.7M | $1.5M | -$0.02 | -$0.03 | $0.01 |
| 03/10/2025 | Q4 | $1.6M | $2.9M | -$0.01 | -$0.03 | $0.02 |
| 11/14/2024 | Q3 | $886.6K | $3.8M | -$0.02 | -$0.03 | $0.01 |
| 08/08/2024 | Q2 | $786K | $1.4M | -$0.03 | -$0.04 | $0.01 |
| 05/09/2024 | Q1 | $1.4M | $1.4M | -$0.04 | -$0.04 | -- |
| 03/07/2024 | Q4 | $2.8M | $2.1M | -$0.02 | -$0.05 | $0.03 |
| 11/09/2023 | Q3 | -- | -- | -$0.04 | -$0.03 | -$0.01 |
| 08/10/2023 | Q2 | -- | -- | -$0.03 | -$0.04 | $0.01 |
| 05/11/2023 | Q1 | -- | -- | -$0.03 | -$0.05 | $0.02 |
| 03/09/2023 | Q4 | -- | -- | -$0.03 | -$0.04 | $0.01 |
| 11/10/2022 | Q3 | -- | -- | -$0.04 | -$0.04 | -- |
| 08/11/2022 | Q2 | -- | -- | -$0.04 | -$0.02 | -$0.02 |
| 05/12/2022 | Q1 | -- | -- | -$0.04 | -$0.06 | $0.02 |
| 03/10/2022 | Q4 | -- | -- | -$0.17 | -$0.05 | -$0.12 |
| 11/10/2021 | Q3 | -- | -- | -$0.05 | -$0.05 | -$0.00 |
| 08/12/2021 | Q2 | -- | -- | -$0.03 | -$0.04 | $0.01 |
| 05/13/2021 | Q1 | -- | -- | -$0.01 | -$0.05 | $0.04 |
| 03/11/2021 | Q4 | -- | -- | $0.01 | -$0.04 | $0.05 |
| 11/04/2020 | Q3 | -- | -- | -$0.05 | -$0.04 | -$0.01 |
| 08/06/2020 | Q2 | -- | -- | -$0.04 | -$0.05 | $0.01 |
| 05/07/2020 | Q1 | -- | -- | -$0.06 | -- | -- |
| 03/12/2020 | Q4 | -- | -- | -$0.03 | -$0.05 | $0.02 |
| 11/12/2019 | Q3 | -- | -- | -$0.11 | -$0.05 | -$0.06 |
| 08/08/2019 | Q2 | -- | -- | -$0.20 | -$0.06 | -$0.15 |
| 05/09/2019 | Q1 | -- | -- | $0.30 | -$0.06 | $0.36 |
| 03/14/2019 | Q4 | -- | -- | -$0.35 | -$0.07 | -$0.28 |
| 11/08/2018 | Q3 | -- | -- | $0.53 | -$0.07 | $0.60 |
| 08/02/2018 | Q2 | -- | -- | -$0.03 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | -$0.50 | -- | -- |
| 03/15/2018 | Q4 | -- | -- | -$0.64 | -- | -- |
| 11/09/2017 | Q3 | -- | -- | $0.12 | -- | -- |
| 08/02/2017 | Q2 | -- | -- | -$0.11 | -- | -- |
| 05/10/2017 | Q1 | -- | -- | $0.46 | -- | -- |
| 03/16/2017 | Q4 | -- | -- | -$0.05 | -- | -- |
| 11/03/2016 | Q3 | -- | -- | $0.30 | -- | -- |
| 08/11/2016 | Q2 | -- | -- | $0.26 | -- | -- |
| 05/17/2016 | Q1 | -- | -- | -$0.19 | -- | -- |
| 03/29/2016 | Q4 | -- | -- | -$0.16 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -$0.18 | -- | -- |
Lineage Cell Therapeutics Earnings Questions
-
How Much did Lineage Cell Therapeutics Generate in Revenue Last Quarter?
Lineage Cell Therapeutics reported $1.5M worth of top line sales in its most recent quarter.
-
Did Lineage Cell Therapeutics Beat Earnings Last Quarter?
Lineage Cell Therapeutics announced earnings per share of -$0.02 which represents a beat of analyst forecast a -$0.03 per share.
-
Is Lineage Cell Therapeutics Profitable?
Lineage Cell Therapeutics reported $1.5M that represents $0.01 per share over the last quarter.
-
What is the Analyst Consensus for Lineage Cell Therapeutics EPS Next Year?
Lineage Cell Therapeutics's earnings are forecast to decrease from -$0.09 per share to -$0.11 per share next year representing a decrease of -16.67%.
-
When is Lineage Cell Therapeutics's Earnings Date?
Lineage Cell Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
